Abstract:The interaction of iron and oxygen is an integral part of the development of life on Earth. Nonetheless, this unique chemistry continues to fascinate and puzzle, leading to new biological ventures. In 2012, a Columbia University group recognized this interaction as a central event leading to a new type of regulated cell death named "ferroptosis." The major feature of ferroptosis is the accumulation of lipid hydroperoxides due to (1) dysfunctional antioxidant defense and/or (2) overwhelming oxidative stress, which most frequently coincides with increased content of free labile iron in the cell. This is normally prevented by the canonical anti-ferroptotic axis comprising the cystine transporter xCT, glutathione (GSH), and GSH peroxidase 4 (GPx4). Since ferroptosis is not a programmed type of cell death, it does not involve signaling pathways characteristic of apoptosis. The most common way to prove this type of cell death is by using lipophilic antioxidants (vitamin E, ferrostatin-1, etc.) to prevent it. These molecules can approach and detoxify oxidative damage in the plasma membrane. Another important aspect in revealing the ferroptotic phenotype is detecting the preceding accumulation of lipid hydroperoxides, for which the specific dye BODIPY C11 is used. The present manuscript will show how ferroptosis can be induced in wild-type medulloblastoma cells by using different inducers: erastin, RSL3, and iron-donor. Similarly, the xCT-KO cells that grow in the presence of NAC, and which undergo ferroptosis once NAC is removed, will be used. The characteristic "bubbling" phenotype is visible under the light microscope within 12-16 h from the moment of ferroptosis triggering. Furthermore, BODIPY C11 staining followed by FACS analysis to show the accumulation of lipid hydroperoxides and consequent cell death using the PI staining method will be used. To prove the ferroptotic nature of cell death, ferrostatin-1 will be used as a specific ferroptosis-preventing agent.

Intracellular biliverdin dynamics during ferroptosis

Targeting Ferroptosis in Breast Cancer

Revealing the Ferroptotic Phenotype of Medulloblastoma

Important molecular mechanisms in ferroptosis

Identification of essential sites of lipid peroxidation in ferroptosis

The cell biology of ferroptosis

Ferroptosis: Iron-mediated cell death linked to disease pathogenesis

Dynamic regulation of ferroptosis by lipid metabolism.

Integrated hepatic ferroptosis gene signature dictates pathogenic features of ferroptosis

Ferroptosis: past, present and future

Understanding the unique mechanism of ferroptosis: a promising therapeutic target

Ferroptosis Biology

Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment

Ferroptosis in Cancer Cell Biology

Lipid peroxidation and the subsequent cell death transmitting from ferroptotic cells to neighboring cells

Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases

Focus on ferroptosis regulation: Exploring novel mechanisms and applications of ferroptosis regulator

Ferroptosis and Its Potential Role in Human Diseases

The prospects of ferroptosis in the pathogenesis of liver disease

Ferroptosis and its clinical significance

Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications